Anderson C - Search Results

1

In vitro testing of chemosensitivity in physiological hypoxia.

Grigoryan R, Keshelava N, Anderson C, Reynolds CP. Grigoryan R, et al. Among authors: anderson c. Methods Mol Med. 2005;110:87-100. doi: 10.1385/1-59259-869-2:087. Methods Mol Med. 2005. PMID: 15901930

2

Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.

Yang B, Keshelava N, Anderson CP, Reynolds CP. Yang B, et al. Among authors: anderson cp. Cancer Res. 2003 Apr 1;63(7):1520-6. Cancer Res. 2003. PMID: 12670899

3

Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.

Gutova M, Goldstein L, Metz M, Hovsepyan A, Tsurkan LG, Tirughana R, Tsaturyan L, Annala AJ, Synold TW, Wan Z, Seeger R, Anderson C, Moats RA, Potter PM, Aboody KS. Gutova M, et al. Among authors: anderson c. Mol Ther Oncolytics. 2016 Dec 14;4:67-76. doi: 10.1016/j.omto.2016.11.004. eCollection 2017 Mar 17. Mol Ther Oncolytics. 2016. PMID: 28345025 Free PMC article.

4

Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro.

Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE. Stone DJ, et al. Among authors: anderson cp. Exp Neurol. 1997 Feb;143(2):313-8. doi: 10.1006/exnr.1996.6360. Exp Neurol. 1997. PMID: 9056393

5

Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.

Anderson CP, Reynolds CP. Anderson CP, et al. Bone Marrow Transplant. 2002 Aug;30(3):135-40. doi: 10.1038/sj.bmt.1703605. Bone Marrow Transplant. 2002. PMID: 12189530

6

Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression.

Anderson CP, Keshelava N, Satake N, Meek WH, Reynolds CP. Anderson CP, et al. Med Pediatr Oncol. 2000 Dec;35(6):659-62. doi: 10.1002/1096-911x(20001201)35:6<659::aid-mpo38>3.0.co;2-4. Med Pediatr Oncol. 2000. PMID: 11107141

7

Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.

Anderson CP, Tsai JM, Meek WE, Liu RM, Tang Y, Forman HJ, Reynolds CP. Anderson CP, et al. Exp Cell Res. 1999 Jan 10;246(1):183-92. doi: 10.1006/excr.1998.4303. Exp Cell Res. 1999. PMID: 9882527

8

Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines.

Anderson CP, Tsai J, Chan W, Park CK, Tian L, Lui RM, Forman HJ, Reynolds CP. Anderson CP, et al. Eur J Cancer. 1997 Oct;33(12):2016-9. doi: 10.1016/s0959-8049(97)00203-7. Eur J Cancer. 1997. PMID: 9516845

9

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP. Villablanca JG, et al. Pediatr Blood Cancer. 2016 Aug;63(8):1349-56. doi: 10.1002/pbc.25994. Epub 2016 Apr 19. Pediatr Blood Cancer. 2016. PMID: 27092812 Clinical Trial.

10

Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro.

Stone DJ, Song Y, Anderson CP, Krohn KK, Finch CE, Rozovsky I. Stone DJ, et al. Among authors: anderson cp. Endocrinology. 1998 Jul;139(7):3202-9. doi: 10.1210/endo.139.7.6084. Endocrinology. 1998. PMID: 9645694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results